The Nutrients Your Body Needs to Produce Sperm

Most people think of sperm production as something that just happens, a background process the body runs on autopilot, and for the most part that is true until the raw materials start running low. The machinery inside the testicles is constant and demanding, turning out roughly a thousand sperm per second across a cycle that takes about 74 days from start to finish, and that machinery has specific input requirements that, when unmet, cause the whole output to decline. There are a couple key ingredients, raw materials that your testicles need to produce sperm, and understanding what those ingredients are and why they matter gives you a much clearer picture of what is actually going on when fertility markers come back low.

The two inputs that matter most are zinc and cholesterol, one being a mineral and the other a lipid your body synthesizes and also pulls from food, and they serve completely different functions in the sperm production pipeline but both converge on the same endpoint, which is the Sertoli cells and Leydig cells inside the testes doing their jobs properly. Sertoli cells are the support structure for developing sperm, nursing them through each stage of maturation, and Leydig cells are the ones that produce testosterone, which is itself a requirement for Sertoli cells to function. So the system is layered and interdependent, and both zinc and cholesterol feed into it at different points.

Zinc is worth looking at first, because it is a cofactor for over 300 enzymatic reactions in the body, but in the context of reproduction it plays a particularly concentrated role because seminal fluid contains one of the highest zinc concentrations of any tissue in the body. The prostate gland accumulates zinc at levels roughly 10 times higher than most other soft tissues, and it secretes that zinc into the seminal plasma where it stabilizes sperm DNA, supports membrane integrity, and influences motility. When zinc status drops, those functions degrade in a measurable way.

The animal research on zinc supplementation and reproductive output is extensive and consistent. A 2021 study published in Biological Trace Element Research by Prabakar and colleagues found that supplementing zinc in the form of zinc methionine significantly improved semen volume, sperm concentration, and motility in broiler breeders compared to inorganic zinc forms. A separate 2020 study in the journal Animals by Abdel-Wareth and colleagues showed that nano-zinc oxide supplementation improved sperm concentration, motility, and overall fertility rates in male rabbits. And work by Arangasamy and colleagues published in Theriogenology in 2018 demonstrated that trace mineral supplementation including zinc advanced puberty onset and enhanced seminal characteristics in male goats, with measurable increases in ejaculate volume and sperm count.

Now, animal models are not human clinical trials, and it is worth being clear about that. But the mechanism is well understood and consistent across species because zinc's role in spermatogenesis is structural, not species-specific. It is needed for the proper folding and function of proteins involved in DNA packaging during sperm maturation, and it is needed for the activity of enzymes like alkaline phosphatase that support Sertoli cell metabolism. The human data that does exist, mostly from observational and small interventional studies, aligns with the animal findings, showing that men with lower seminal zinc levels tend to have lower sperm counts and reduced motility.

Which is why supplementation makes practical sense as a baseline intervention. Typically 15 to 30 milligrams per day is sufficient, and it works wonders for not only improving fertility, but also semen volume. That dosage range sits comfortably within the tolerable upper intake level for adults, which is 40 milligrams per day, so you have a reasonable margin of safety. The form of zinc matters somewhat because bioavailability varies. Zinc picolinate, zinc bisglycinate, and zinc methionine tend to absorb more efficiently than zinc oxide, which is the cheapest and most common form in generic supplements. If you are supplementing specifically for reproductive outcomes, choosing a chelated form is a small decision that can affect how much of that 15 to 30 milligrams actually reaches the tissues that need it.

One thing worth noting is that zinc competes with copper for absorption, so long-term zinc supplementation without attention to copper intake can push copper levels low, which creates its own set of problems including immune suppression and connective tissue issues. Many zinc supplements now include a small amount of copper for this reason, and if yours does not, monitoring copper status through periodic blood work or simply eating copper-rich foods like liver, shellfish, or dark chocolate can keep things balanced.

Now the second substrate, and this one surprises people more than zinc does because it runs against decades of public health messaging. Cholesterol is the direct precursor molecule for all steroid hormones in the body, including testosterone. The biosynthetic pathway is straightforward: cholesterol is converted to pregnenolone, which is converted to DHEA, which is converted to androstenedione, which is finally converted to testosterone. Every step in that chain starts with cholesterol. Without adequate cholesterol availability inside the Leydig cells, the very first conversion cannot happen at a sufficient rate, and testosterone output drops. And when testosterone drops, Sertoli cell function declines, and sperm production follows.

The research on this actually bears out that concern, because a 2023 study by Liu and colleagues published in Hormones found that rats fed a high cholesterol diet experienced testicular dysfunction, but the mechanism was not the presence of cholesterol itself and was instead the downstream metabolic disruption caused by extreme hyperlipidemia, including oxidative stress and inflammatory signaling in testicular tissue. The critical takeaway is that cholesterol in normal physiological ranges is not just harmless to testicular function, it is required for it, and the problem only emerges at extremes where even then the damage comes from inflammation and oxidative stress rather than from cholesterol acting as a toxin.

Separate research by Gao and colleagues published in Science of the Total Environment in 2022 showed that endocrine-disrupting compounds like bisphenol A interfere with testicular function specifically by disrupting cholesterol homeostasis through activation of a receptor called PPARα, which alters the way Leydig cells uptake and process cholesterol for steroid synthesis. The toxicity was not from having too much or too little cholesterol in the blood. It was from the disruption of how cholesterol was being handled at the cellular level inside the testes. This reinforces the point that cholesterol availability and cholesterol metabolism within the reproductive system are both active requirements for sperm and testosterone production, not passive background features.

Statins are where this gets complicated and worth paying attention to, especially if you are on one of them, because if your LDL and HDL cholesterol are both being driven down aggressively you are probably going to have a hard time producing sperm and testosterone. Statins work by inhibiting HMG-CoA reductase, the enzyme that catalyzes the rate-limiting step in the body's own cholesterol synthesis pathway, and they are extremely effective at lowering LDL cholesterol, which is exactly what they are designed to do, and in populations with established cardiovascular disease or very high risk profiles they save lives and nobody is disputing that. But the downstream effect on steroid hormone production is real and measurable, particularly in men whose cholesterol drops into very low ranges across both LDL and HDL fractions.

The concern is not about statins being categorically harmful. It is about understanding that the body uses LDL particles to deliver cholesterol to tissues that need it, including the testes, and when that delivery system is suppressed aggressively, reproductive tissues can become substrate-limited. HDL also plays a role because Leydig cells can take up cholesterol from HDL through a receptor called SR-B1, so when both fractions are low simultaneously, the testicular supply of the primary raw material for testosterone production is genuinely compromised.

This leads naturally to a broader point about how we interpret lipid panels. LDL as a high number on your labs isn't necessarily an indication that you're going to have heart problems or a heart attack or you're at risk of a cardiac event. That statement tends to catch people off guard because the simplified public health message for decades has been that LDL equals bad and lower equals better. And there is truth embedded in that message, because elevated LDL is associated with atherosclerotic plaque development in large population studies, and that association is real. But association and causation are different things, and the context that gets lost is that LDL only becomes dangerous when it penetrates and lodges in the arterial wall, and that penetration is driven much more strongly by particle number, particle size, and local inflammation than by the total concentration of LDL cholesterol alone.

This is where more advanced lipid markers come in. ApoB, or apolipoprotein B, is a protein found on every atherogenic lipoprotein particle, which means it gives you a direct count of how many particles are circulating that could potentially contribute to plaque formation. Two people can have identical LDL cholesterol numbers but very different ApoB counts because the cholesterol can be distributed across fewer large particles or many small dense particles, and the latter scenario carries more risk. A 2022 review by Sykes and colleagues in Current Cardiology Reports laid out the case for integrating ApoB and other advanced markers into standard lipid assessment precisely because LDL cholesterol alone fails to capture this particle-level risk.

The other marker that matters is hs-CRP, or high-sensitivity C-reactive protein, which is a general marker of systemic inflammation. Inflammation is what determines whether circulating LDL particles actually damage the arterial lining, because an inflamed endothelium is a permeable endothelium, and that is what allows LDL particles to infiltrate and start the plaque cascade. So if your LDL is elevated but your hs-CRP is low and your ApoB is low, the actual mechanistic conditions for atherosclerosis are not present at a meaningful level, and the elevated LDL number on its own is telling you much less than you might assume.

None of this means you should ignore high LDL or refuse to discuss statins with your doctor. It means that the decision to aggressively lower cholesterol should factor in the full picture, including reproductive goals, hormone status, and the more granular cardiovascular markers that tell you whether that LDL is actually doing damage or just circulating. For a man trying to conceive or maintain healthy testosterone production, driving cholesterol into the floor without checking ApoB, hs-CRP, and hormone panels is solving one potential problem while potentially creating another.

The practical layer of all this is surprisingly simple. Ensuring adequate zinc intake through supplementation at 15 to 30 milligrams per day in a well-absorbed form covers the mineral side of spermatogenesis. Ensuring adequate dietary fat and cholesterol intake, meaning you are not chronically restricting fat to very low levels, covers the hormonal substrate side. Eating whole eggs, fatty fish, olive oil, and animal fats in reasonable amounts provides both cholesterol and the omega-3 fatty acids that research by He and colleagues in the International Journal of Biological Sciences has shown protect Sertoli cells from senescence and maintain the structural connections between mitochondria and endoplasmic reticulum that Sertoli cells depend on for energy metabolism during sperm support.

A 2023 review in the European Journal of Translational Myology by Cupka and Sedliak specifically connected low energy availability in male endurance athletes to suppressed testosterone, reinforcing the point that caloric and fat restriction has a direct line to reproductive hormone output. If you are eating in a deep deficit, or if you are running on very low dietary fat, your body will downregulate reproductive function before it downregulates anything else because from an evolutionary standpoint, reproduction is the first thing to go when resources are scarce.

The body does not produce sperm from willpower or from protein or from any single macronutrient in isolation, and it produces sperm from a specific set of substrates delivered to a specific set of cells under the influence of specific hormones that themselves require those same substrates to be synthesized, so zinc feeds the enzymatic machinery and cholesterol feeds the hormonal machinery and the inflammation context of your cardiovascular system determines whether keeping that cholesterol available is a risk or simply a biological necessity being met. When you understand that chain, a low sperm count stops looking like a mysterious diagnosis and starts looking like a supply chain problem with identifiable inputs you can actually adjust.

References:

Prabakar G, Gopi M, Kolluri G et al.. Effect of Supplementation of Zinc-Methionine on Egg Production, Semen Quality, Reproductive Hormones, and Hatchability in Broiler Breeders. Biol Trace Elem Res. 2021. https://pubmed.ncbi.nlm.nih.gov/33496884/

Abdel-Wareth AAA, Al-Kahtani MA, Alsyaad KM et al.. Combined Supplementation of Nano-Zinc Oxide and Thyme Oil Improves the Nutrient Digestibility and Reproductive Fertility in the Male Californian Rabbits. Animals (Basel). 2020. https://pubmed.ncbi.nlm.nih.gov/33261201/

Arangasamy A, Venkata Krishnaiah M, Manohar N et al.. Advancement of puberty and enhancement of seminal characteristics by supplementation of trace minerals to bucks. Theriogenology. 2018. https://pubmed.ncbi.nlm.nih.gov/29407900/

Thirumalai A, Page ST. Recent Developments in Male Contraception. Drugs. 2019. https://pubmed.ncbi.nlm.nih.gov/30588563/

Gao Z, Liu S, Tan L et al.. Testicular toxicity of bisphenol compounds: Homeostasis disruption of cholesterol/testosterone via PPARα activation. Sci Total Environ. 2022. https://pubmed.ncbi.nlm.nih.gov/35504394/

Liu L, Zhang M, Jiang F et al.. High cholesterol diet-induced testicular dysfunction in rats. Hormones (Athens). 2023. https://pubmed.ncbi.nlm.nih.gov/37596375/

Wharton S, Rosenstock J, Konige M et al.. Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes. Cardiovasc Diabetol. 2025. https://pubmed.ncbi.nlm.nih.gov/40481478/

Reddy S, Deoker A. Effects of bempedoic acid on markers of inflammation and Lp(a). Curr Opin Cardiol. 2024. https://pubmed.ncbi.nlm.nih.gov/38456474/

Sykes AV, Patel N, Lee D et al.. Integrating Advanced Lipid Testing and Biomarkers in Assessment and Treatment. Curr Cardiol Rep. 2022. https://pubmed.ncbi.nlm.nih.gov/36001215/

Cupka M, Sedliak M. Hungry runners - low energy availability in male endurance athletes and its impact on performance and testosterone: mini-review. Eur J Transl Myol. 2023. https://pubmed.ncbi.nlm.nih.gov/37052052/

He Z, Ge F, Li C et al.. The Remodeling of Mitochondrial-Endoplasmic Reticulum Contacts by Omega-3 Fatty Acids Mitigates Dietary Advanced Glycation End Product-Driven Sertoli Cell Senescence and Oligoasthenozoospermia. Int J Biol Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/41208893/

Vesal S, Hashemi Karoii D, Shams AA et al.. Differential expression of Pparγ target genes in testis of rats under theinfluence of paternal trans fatty acid and vitamin-E. Cell J. 2026. https://pubmed.ncbi.nlm.nih.gov/42001274/